Dramatic Aggregation of Alzheimer Aβ by Cu(II) is Induced by Conditions Representing Physiological Acidosis
Craig S. Atwood,Robert D. Moir,Xudong Huang,Richard C. Scarpa,N. Michael E. Bacarra,Donna M. Romano,Mariana A. Hartshorn,Rudolph E. Tanzi,Ashley I. Bush
DOI: https://doi.org/10.1074/jbc.273.21.12817
IF: 5.485
1998-01-01
Journal of Biological Chemistry
Abstract:The cortical deposition of Aβ is an event that occurs in Alzheimer's disease, Down's syndrome, head injury, and normal aging. Previously, in appraising the effects of different neurochemical factors that impact upon the solubility of Aβ, we observed that Zn2+ was the predominant bioessential metal to induce the aggregation of soluble Aβ at pH 7.4 in vitro and that this reaction is totally reversible with chelation. We now report that unlike other biometals tested at maximal biological concentrations, marked Cu2+-induced aggregation of Aβ1–40 emerged as the solution pH was lowered from 7.4 to 6.8 and that the reaction was completely reversible with either chelation or alkalinization. This interaction was comparable to the pH-dependent effect of Cu2+ on insulin aggregation but was not seen for aprotinin or albumin. Aβ1–40 bound three to four Cu2+ ions when precipitated at pH 7.0. Rapid, pH-sensitive aggregation occurred at low nanomolar concentrations of both Aβ1–40 and Aβ1–42 with submicromolar concentrations of Cu2+. Unlike Aβ1–40, Aβ1–42was precipitated by submicromolar Cu2+ concentrations at pH 7.4. Rat Aβ1–40 and histidine-modified human Aβ1–40 were not aggregated by Zn2+, Cu2+, or Fe3+, indicating that histidine residues are essential for metal-mediated Aβ assembly. These results indicate that H+-induced conformational changes unmask a metal-binding site on Aβ that mediates reversible assembly of the peptide. Since a mildly acidic environment together with increased Zn2+ and Cu2+ are common features of inflammation, we propose that Aβ aggregation by these factors may be a response to local injury. Cu2+, Zn2+, and Fe3+ association with Aβ explains the recently reported enrichment of these metal ions in amyloid plaques in Alzheimer's disease. The cortical deposition of Aβ is an event that occurs in Alzheimer's disease, Down's syndrome, head injury, and normal aging. Previously, in appraising the effects of different neurochemical factors that impact upon the solubility of Aβ, we observed that Zn2+ was the predominant bioessential metal to induce the aggregation of soluble Aβ at pH 7.4 in vitro and that this reaction is totally reversible with chelation. We now report that unlike other biometals tested at maximal biological concentrations, marked Cu2+-induced aggregation of Aβ1–40 emerged as the solution pH was lowered from 7.4 to 6.8 and that the reaction was completely reversible with either chelation or alkalinization. This interaction was comparable to the pH-dependent effect of Cu2+ on insulin aggregation but was not seen for aprotinin or albumin. Aβ1–40 bound three to four Cu2+ ions when precipitated at pH 7.0. Rapid, pH-sensitive aggregation occurred at low nanomolar concentrations of both Aβ1–40 and Aβ1–42 with submicromolar concentrations of Cu2+. Unlike Aβ1–40, Aβ1–42was precipitated by submicromolar Cu2+ concentrations at pH 7.4. Rat Aβ1–40 and histidine-modified human Aβ1–40 were not aggregated by Zn2+, Cu2+, or Fe3+, indicating that histidine residues are essential for metal-mediated Aβ assembly. These results indicate that H+-induced conformational changes unmask a metal-binding site on Aβ that mediates reversible assembly of the peptide. Since a mildly acidic environment together with increased Zn2+ and Cu2+ are common features of inflammation, we propose that Aβ aggregation by these factors may be a response to local injury. Cu2+, Zn2+, and Fe3+ association with Aβ explains the recently reported enrichment of these metal ions in amyloid plaques in Alzheimer's disease. Aβ, a low molecular weight (39–43 amino acids) protein that is a proteolytic product derived from the larger amyloid precursor protein (1Kang J. Lemaire H.G. Unterbeck A. Salbaum J.M. Masters C.L. Grzeschik K.-H. Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (3789) Google Scholar, 2Goldgaber D. Lerman M.I. McBride O.W. Saffioti U. Gajdusek D.C. Science. 1987; 235: 877-880Crossref PubMed Scopus (1104) Google Scholar, 3Tanzi R.E. Gusella J.F. Watkins P.C. Bruns G.A. St George-Hyslop P. Van Keuren M.L. Patterson D. Pagan S. Kurnit D.M. Neve R.L. Science. 1987; 235: 880-884Crossref PubMed Scopus (1307) Google Scholar), is the major component of neocortical amyloid collections in Alzheimer's disease (AD 1The abbreviations used are: AD, Alzheimer's disease; DS, Down's syndrome; DEPC, diethyl pyrocarbonate; Tricine,N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; MES, 4-morpholineethanesulfonic acid; BSA, bovine serum albumin.; see Refs. 4Maury C.P.J. Lab. Invest. 1995; 72: 4-16PubMed Google Scholar and 5Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (4151) Google Scholar). As is the case with other amyloid proteins, Aβ originates as a normally soluble and constitutive protein found in biological fluids and tissue (6Shoji M. Golde T. Ghiso J. Cheung T.T. Estus S. Shaffer L.M. Cai X.D. McKay D.M. Tintner R. Frangione B. Younkin S.G. Science. 1992; 258: 126-129Crossref PubMed Scopus (1334) Google Scholar, 7Haass C. Schlossmacher M. Hung A. Vigo-Pelfrey C. Mellon A. Ostaszewski B.L. Lieberburg I. Koo E.H. Schenk D. Teplow D.B. Selkoe D.S. Nature. 1992; 359: 322-325Crossref PubMed Scopus (1832) Google Scholar, 8Seubert P. Vigo-Pelfrey C. Esch F. Nature. 1992; 359: 325-327Crossref PubMed Scopus (1666) Google Scholar, 9Tabaton M. Nunzi M.G. Xue R. Usiak M. Autilio-Gambetti L. Gambetti P. Biochem. Biophys. Res. Commun. 1994; 200: 1598-1603Crossref PubMed Scopus (134) Google Scholar, 10Koudinov A. Matsubara E. Frangione B. Ghiso J. Biochem. Biophys. Res. Commun. 1994; 205: 1164-1171Crossref PubMed Scopus (136) Google Scholar, 11Nakamura T. Shoji M. Harigaya Y. Watanabe M. Hosoda K. Cheung T.T. Shaffer L.M. Golde T.E. Younkin L.H. Younkin S.G. Hirai S. Ann. Neurol. 1994; 36: 903-911Crossref PubMed Scopus (98) Google Scholar, 12Motter R. Vigo-Pelfrey C. Kholodenko M.S. Barbour B.S. Johnson-Wood K. Galasko D. Chang L. Miller B. Clark C. Green R. Olsen D. Southwick P. Wolfert R. Munroe B. Lieberburg I. Seubert P. Schenk D. Ann. Neurol. 1995; 38: 643-648Crossref PubMed Scopus (649) Google Scholar, 13Nitsch R.M. Rebeck G.W. Deng M. Richardson U.I. Tennis M. Schenk D.B. Vigo-Pelfrey C. Lieberburg I. Wurtman R.J. Hyman B.T. Growdon J.H. Ann. Neurol. 1995; 37: 512-518Crossref PubMed Scopus (116) Google Scholar, 14Southwick P.C. Yamagata S.K. Echols Jr., C.L. Higson G.J. Neynaber S.A. Parson R.E. Munroe W.A. J. Neurochem. 1996; 66: 259-265Crossref PubMed Scopus (91) Google Scholar, 15Ida N. Hartmann T. Pantel J. Schroder J. Zerfass R. Forstl H. Sandbrink R. Masters C.L. Beyreuther K. J. Biol. Chem. 1996; 271: 22908-22914Abstract Full Text Full Text PDF PubMed Scopus (474) Google Scholar). Aβ also aggregates to form diffuse amorphous deposits in AD but also following head injury (16Roberts G.W. Gentleman S.M. Lynch A. Graham D.I. Lancet. 1991; 338: 1422-1423Abstract PubMed Scopus (432) Google Scholar, 17Roberts G.W. Gentleman S.M. Lynch A. Murray L. Landon M. Graham D.I. J. Neurol. Neurosurg. Psychiatry. 1994; 57: 419-425Crossref PubMed Scopus (514) Google Scholar, 18Graham D.I. Gentleman S.M. Lynch A. Roberts G.W. Neuropathol. Appl. Neurobiol. 1995; 21: 27-34Crossref PubMed Scopus (136) Google Scholar) and in healthy aged individuals (19Mackenzie I. J. Neuropathol. Exp. Neurol. 1993; 156: 437-442Google Scholar). Combined with other inflammatory proteins such as proteoglycans (20Snow A.D. Sekiguchi R. Nochlin D. Fraser P. Kimata K. Mizutani A. Arai M. Schreier W.A. Morgan D.G. Neuron. 1994; 12: 219-234Abstract Full Text PDF PubMed Scopus (283) Google Scholar), amyloid P-component (21Coria F. Castanño E. Prelli F. Larrondo-Lillo M. van Duinen S. Shelanski M.L. Frangione B. Lab. Invest. 1988; 58: 454-458PubMed Google Scholar), and apolipoprotein E (22Chan W. Fornwald J. Brawner M. Wetzel R. Biochemistry. 1996; 35: 7123-7130Crossref PubMed Scopus (61) Google Scholar, 23Prior R. Durso D. Frank R. Prikulis I. Cleven S. Ihl R. Pavlakovic G. Am. J. Pathol. 1996; 148: 1749-1756PubMed Google Scholar), Aβ is found in the brains of individuals affected by AD and Down's syndrome (DS) as dense extracellular deposits of twisted β-pleated sheet fibrils in the neuropil (senile plaques) and within cerebral blood vessels (amyloid congophilic angiopathy; see Refs. 4Maury C.P.J. Lab. Invest. 1995; 72: 4-16PubMed Google Scholar and 5Multhaup G. Beyreuther K. Muller-Hill B. Nature. 1987; 325: 733-736Crossref PubMed Scopus (4151) Google Scholar). The deposition of Aβ, however, is not confined to the brain parenchyma, having been detected in amyloid diseases of the muscle (24Askanas V. Engel W.K. Curr. Opin. Rheumatol. 1993; 5: 732-741Crossref PubMed Scopus (82) Google Scholar, 25Murakami N. Ihara Y. Nonaka I. Acta Neuropathol. 1995; 89: 29-34Crossref PubMed Scopus (36) Google Scholar, 26Davis-Salinas J. Saporito-Irwin S.M. Cotman C.W. Van Nostrand W.E. J. Neurochem. 1995; 65: 931-934Crossref PubMed Scopus (159) Google Scholar), blood vessels (27Glenner G.C. Wong C.W. Biochem. Biophys. Res. Commun. 1984; 120: 885-890Crossref PubMed Scopus (4433) Google Scholar, 28Joachim C.L. Duffy L.K. Morris J.H. Selkoe D.J. Brain Res. 1988; 474: 100-111Crossref PubMed Scopus (161) Google Scholar), and in the kidneys, lungs, skin, subcutaneous tissue, and intestine of AD patients (29Skodras G. Peng J.H. Parker Jr., J.C. Kragel P.J. Ann. Clin. Lab. Sci. 1993; 23: 275-280PubMed Google Scholar, 30Joachim C.L. Mori H. Selkoe D.J. Nature. 1989; 341: 226-230Crossref PubMed Scopus (412) Google Scholar). Cerebral Aβ deposition occurs in other aged mammals that have the human Aβ sequence (31Vaughan D.W. Peters A. J. Neuropathol. Exp. Neurol. 1981; 40: 472-487Crossref PubMed Scopus (70) Google Scholar) but is not a feature of aged rats (32Johnstone E.M. Chaney M.O. Norris F.H. Pascual R. Little S.P. Mol. Brain Res. 1991; 10: 229Crossref Scopus (307) Google Scholar, 33Shivers B.D. Hilbich C. Multhaup G. Salbaum M. Beyreuther K. Seeburg P.H. EMBO J. 1988; 7: 1365-1370Crossref PubMed Scopus (410) Google Scholar). Although soluble Aβ1–40 is produced by rat neuronal tissue (34Busciglio J. Gabuzda D.H. Matsudaira P. Yanker B.A. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2092-2096Crossref PubMed Scopus (550) Google Scholar), it contains three amino acid substitutions (Arg → Gly, Tyr → Phe, and His → Arg at positions 5, 10, and 13, respectively (32Johnstone E.M. Chaney M.O. Norris F.H. Pascual R. Little S.P. Mol. Brain Res. 1991; 10: 229Crossref Scopus (307) Google Scholar)) that appear to alter the physicochemical properties of the peptide preventing it from precipitating in the neocortex. Aβ accumulates in the brain in AD and DS in forms that can be resolubilized in water (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 36Roher A.E. Chaney M.O. Kuo Y.-M. Webster S.D. Stine W.B. Haverkamp L.J. Woods A.S. Cotter R.J. Tuohy J.M. Krafft G.A. Bonnell B.S. Emmerling M.R. J. Biol. Chem. 1996; 271: 20631-20635Abstract Full Text Full Text PDF PubMed Scopus (466) Google Scholar) but also in forms that require harsher conditions to extract and exhibit associated SDS-resistant polymerization on polyacrylamide gel electrophoresis (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 37Masters C.L. Simms G. Weinman N.A. Multhaup G. McDonald B.L. Beyreuther K. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4245-4249Crossref PubMed Scopus (3842) Google Scholar). Aβ1–40 is the predominant soluble species in biological fluids, whereas Aβ1–42, a minor species of Aβ that is more insoluble in vitro, is the predominant species found in plaques and deposits associated with AD and DS (35Kuo Y.-M. Emmerling M.R. Vigo-Pelfrey C. Kasunic T.C. Kirkpatrick J.B. Murdoch G.H. Ball M.J. Roher A.E. J. Biol. Chem. 1996; 271: 4077-4081Abstract Full Text Full Text PDF PubMed Scopus (559) Google Scholar, 36Roher A.E. Chaney M.O. Kuo Y.-M. Webster S.D. Stine W.B. Haverkamp L.J. Woods A.S. Cotter R.J. Tuohy J.M. Krafft G.A. Bonnell B.S. Emmerling M.R. J. Biol. Chem. 1996; 271: 20631-20635Abstract Full Text Full Text PDF PubMed Scopus (466) Google Scholar, 37Masters C.L. Simms G. Weinman N.A. Multhaup G. McDonald B.L. Beyreuther K. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4245-4249Crossref PubMed Scopus (3842) Google Scholar, 38Murphy Jr., G.M. Forno L.S. Higgins L. Scardina J.M. Eng L.F. Cordell B. Am. J. Pathol. 1994; 144: 1082-1088PubMed Google Scholar, 39Mak K. Yang F. Vinters H.V. Frautschy S.A. Cole G.M. Brain Res. 1994; 667: 138-142Crossref PubMed Scopus (67) Google Scholar, 40Iwatsubo T. Mann D.M.A. Odaka A. Suzuki N. Ihara Y. Ann. Neurol. 1995; 37: 294-299Crossref PubMed Scopus (342) Google Scholar, 41Mann D.M.A. Iwatsubo T. Ihara Y. Cairns N.J. Lantos P.L. Bogdanovic N. Lannfelt L. Winblad B. Maat-Schieman M.L.C. Rossor M.N. Am. J. Pathol. 1996; 148: 1257-1266PubMed Google Scholar). We have pursued studies of the physicochemical properties of synthetic Aβ peptides in order to appraise the potential of various neurochemical environments to induce Aβ deposition. To this end, we had previously found that Aβ is strikingly precipitated by certain metals in vitro, in particular Zn2+ (42Bush A.I. Pettingell Jr., W.H. Paradis M.D. Tanzi R.E. J. Biol. Chem. 1994; 269: 12152-12158Abstract Full Text PDF PubMed Google Scholar, 43Bush A.I. Pettingell Jr., W.H. Multhaup G. Paradis M.D. Vonsattel J.-P. Gusella J.F. Beyreuther K. Masters C.L. Tanzi R.E. Science. 1994; 265: 1464-1467Crossref PubMed Scopus (1441) Google Scholar, 44Bush A.I. Moir R.D. Rosenkranz K.M. Tanzi R.E. Science. 1995; 268: 1921-1922Crossref PubMed Scopus (32) Google Scholar, 45Huang X. Atwood C.S. Moir R.D. Hartshorn M.A. Vonsattel J.-P. Tanzi T.E. Bush A.I. J. Biol. Chem. 1997; 272: 26464-26470Abstract Full Text Full Text PDF PubMed Scopus (313) Google Scholar). This is important since zinc and other biometals are concentrated in the brain neocortical parenchyma. A recent study, using micro particle-induced x-ray emission analyses of the cortical and accessory basal nuclei of the amygdala, demonstrated that levels of Zn2+, Fe3+, and Cu2+ are significantly elevated within AD neuropil compared with control neuropil and that these metal ions are significantly further concentrated within the core and periphery of plaque deposits (46Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998)J. Neurol. Sci., in pressGoogle Scholar). We have also found that the extraction of Aβ deposits from brain tissue into aqueous buffers is increased in the presence of chelators of Zn2+ and Cu2+ (47Cherny R. Masters C.L. Beyreuther K. Tanzi R.E. Fairlie D. Bush A.I. Soc. Neurosci. Abstr. 1997; 23: 534Google Scholar), providing further evidence that these metal ions participate in the deposition of Aβ within amyloid plaques. In common with the appearance of amorphous and amyloid deposits is the observation that altered neuronal H+ homeostasis may accompany Alzheimer's disease and head injury. AD is complicated by cerebral acidosis (pH 6.6; see Ref. 48Yates C.M. Butterworth J. Tennant M.C. Gordon A. J. Neurochem. 1990; 55: 1624-1630Crossref PubMed Scopus (247) Google Scholar), which may be related to impaired glucose metabolism (49Messier C. Gagnon M. Behav. Brain Res. 1996; 75: 1-11Crossref PubMed Scopus (206) Google Scholar) or to the inflammatory response seen in AD-affected brain tissue (reviewed in Refs. 50Griffin W.S.T. Sheng J.G. Mrak R.E. Wasco W. Tanzi R.E. Molecular Mechanisms of Dementia. Humana Press Inc., Totowa, NJ1997: 169-176Crossref Google Scholar and 51Rogers J. O'Barr S. Wasco W. Tanzi R.E. Molecular Mechanisms of Dementia. Humana Press Inc., Totowa, NJ1997: 177-198Crossref Google Scholar). The release of metal ions such as Cu+ and Fe2+ from metalloproteins is induced by a mildly acidotic environment (52Owen Jr., C.A. Proc. Soc. Exp. Biol. Med. 1975; 149: 681-682Crossref PubMed Scopus (13) Google Scholar, 53Princiotto J.V. Zapolski E.J. Biochim. Biophys. Acta. 1976; 428: 766-771Crossref PubMed Scopus (22) Google Scholar, 54Lestas A.N. Br. J. Haematol. 1976; 32: 341-350Crossref PubMed Scopus (100) Google Scholar, 55Baldwin D.A. De Sousa D.M.R. Von Wandruszka R.M.A. Biochim. Biophys. Acta. 1982; 719: 140-146Crossref PubMed Scopus (53) Google Scholar, 56Wardeska J.G. Viglione B.J. Chasteen N.D. Spik G. Montreuil J. Crichton R.R. Mazurier J. Proteins of Iron Storage and Transport. Elsevier Science Publishers B, 1985: 85-88Google Scholar, 57Brieland J.K. Fantone J.C. Arch. Biochem. Biophys. 1991; 284: 78-83Crossref PubMed Scopus (51) Google Scholar, 58Lamb D.J. Leake D.S. FEBS Lett. 1994; 338: 122-126Crossref PubMed Scopus (88) Google Scholar). Therefore, we investigated the effect of several bioessential metal ions on their ability to bind and alter the solubility of Aβ1–40/42 under mildly acidic conditions (pH ≥ 6.6) to determine whether there are any unforeseen interactions that may help explain the propensity for Aβ to precipitate under the mildly acidotic conditions anticipated within the metabolically diseased brain parenchyma. A striking and unexpected interaction between pH and Cu2+ was observed for human Aβ. Human Aβ1–40peptide was synthesized, purified, and characterized by high pressure liquid chromatography analysis (HPLC), amino acid analysis, and mass spectroscopy by the W. M. Keck Foundation Biotechnology Resource Laboratory (Yale University, New Haven, CT). Rat Aβ1–40was obtained from Quality Control Biochemicals, Inc. (Hopkington, MA). The HPLC elution profiles of both peptides in these working batches were identified as a single peak. Amino acid analysis of the synthetic peptides indicated no apparent chemical modifications in the amino acid residues. Synthetic Aβ peptide solutions were dissolved in trifluoroethanol (30% in Milli-Q water (Millipore Corp., Milford, MA)) or 20 mm Hepes (pH 8.5) at a concentration of 0.5–1.0 mg/ml, centrifuged for 20 min at 10,000 × g, and the supernatants (stock Aβ) used for subsequent aggregation assays on the day of the experiment. Prior to use all buffers and stock solutions of metal ions were filtered though a 0.22-μm filter (Gelman Sciences, Ann Arbor, MI) to remove any particulate matter. All metal ions were the chloride salt, except lead nitrate. The concentration of stock Aβ peptides, bovine serum albumin (BSA; Pierce), aprotinin (Sigma), and insulin (Sigma) was determined by spectrophotometric absorbance at 214 nm (against calibrated standard curves) or by Micro BCA protein assay (Pierce). The Micro BCA assay was performed by diluting 10 μl of stock Aβ (or BSA standard) in distilled, deionized water (140 μl) and then adding BCA reagent (150 μl) to a 96-well plate and measuring the absorbance at 562 nm. The validity of this assay was previously confirmed by amino acid analysis. To determine the centrifugation time required to completely sediment aggregated proteins, Aβ1–40 (2.5 μm) in 150 mm NaCl and 20 mm Hepes (pH 7.4) was incubated for 30 min at 37 °C with no metal, and under aggregating conditions of Zn2+ (100 μm), Cu2+ (100 μm), or pH 5.5. Reaction mixtures were centrifuged at 10,000 × g for different times or ultracentrifuged at 100,000 × g for 1 h. Centrifugation for >10 min at 10,000 × g was sufficient to completely sediment Zn2+-, Cu2+-, and pH-induced aggregates of Aβ1–40 when compared with ultracentrifugation (100,000 × g for 1 h). Therefore, centrifugation for 10–20 min at 10,000 × g was used in subsequent assays to sediment aggregated particles. To quantitate the effects of different metals and pH on protein solubility, synthetic Aβ stock, and BSA, aprotinin and insulin stocks were diluted to 2.5 μm in 150 mm NaCl in either 20 mm glycine (pH 3.0–4.5), MES (pH 5.0–6.2), or Hepes (pH 6.4–8.8) and then incubated (37 °C) with or without metal ions for 30 min. The resultant aggregated particles were sedimented by centrifugation (20 min, 10,000 × g), and soluble protein was measured in the supernatant by the Micro BCA protein assay. Cu2+ concentrations were determined using the spectrophotometric method of Matsuba and Takahashi (59Matsuba Y. Takahashi Y. Anal. Biochem. 1970; 36: 182-191Crossref PubMed Scopus (27) Google Scholar), adapted to microtiter plate volumes. Sample Cu2+ concentrations were determined from a Cu2+ standard curve (0–100 μm in 20 mm ammonium acetate, 150 mm NaCl (pH 7.4)). Cu2+-induced spectral changes in Aβ were monitored by incubating Aβ1–40 or Aβ1–42 (5 μm) in 20 mm ammonium acetate buffer, 150 mm NaCl (pH 7.4), with and without various concentrations of Cu2+ for 5 min prior to loading onto a quartz microtiter plate. Absorbance was scanned between 200 and 800 nm on a Spectramax Plus Spectrophotometer (Molecular Devices, Sunnyvale, CA). Incubation of Cu2+ with Aβ induced a change in the absorbance profile of the peptide which was maximal at 208 nm. However, subsequent analyses were performed at 214 nm where the spectral shift was still large but the background signal was lower. By using Aβ aggregation as an end point for Cu2+ binding, the stoichiometry of Cu2+ binding to Aβ1–40was determined by incubating Aβ1–40 (10 μm) in 20 mm ammonium acetate, 150 mm NaCl (pH 7.4) for 30 min at 37 °C with Cu2+ or Cu2+-(glycine)2 (50 μm) (60Masuoka J. Hegenauer J. Van Dyke B.R. Saltman P. J. Biol. Chem. 1993; 268: 21533-21537Abstract Full Text PDF PubMed Google Scholar). Reaction mixtures were centrifuged at 10,000 × g for 20 min, and the ratio of Cu2+ binding to Aβ was estimated by determining the concentrations of soluble Aβ and Cu2+ remaining in the supernatant. It was determined that the presence of Aβ did not affect the assay. Turbidity measurements, as an assay for aggregation, were performed in a flat-bottomed 96-well microtiter plate (Corning Costar Corp.), and absorbances (405 nm) were measured using a Spectramax Plus spectrophotometric microplate reader (Molecular Devices, Sunnyvale, CA). Automatic 30-s plate agitation mode was selected for the plate reader to evenly suspend the aggregates in the wells before all readings. Aβ1–40 stock was brought to 10 μm (300 μl) in 20 mm Hepes buffer, 150 mm NaCl (pH 6.6, 6.8 or 7.4) ± metal ions prior to incubation (30 min, 37 °C) and absorbance measurement. To investigate the reversibility of Cu2+-induced Aβ aggregation, 25 μm Aβ1–40 and 25 μm Cu2+ were mixed in 67 mmphosphate buffer containing 150 mm NaCl (pH 7.4), to a final volume of 200 μl. Turbidity measurements were taken at four 1-min intervals. Subsequently, 20-μl aliquots of 10 mmEDTA or 10 mm Cu2+ were added to the wells alternatively, and following a 2-min delay, a further four readings were taken at 1-min intervals. After the final EDTA addition and turbidity reading, the mixtures were incubated for an additional 30 min before taking final readings. To investigate the reversibility of pH-mediated Cu2+-induced Aβ1–40 aggregation, 10 μm Aβ1–40 and 30 μmCu2+ were mixed in 67 mm phosphate buffer containing 150 mm NaCl (pH 7.4), and an initial turbidity measurement was taken. Subsequently, the pH of the solution was successively decreased to 6.6 with 0.1 m HCl and then increased back to 7.4 with 0.1 m NaOH. The pH of the reaction was monitored with a microprobe (Lazar Research Laboratories Inc., Los Angeles, CA) and the turbidity read at 5-min intervals for up to 30 min. This cycle was repeated three times. Blockage of histidine residues was achieved by incubating Aβ1–40 (1.5 mg/ml dissolved in distilled, deionized H2O, following centrifugation (10,000 × g for 20 min) to remove undissolved peptide) with 5 mm diethyl pyrocarbonate (DEPC) in 25 mm phosphate buffer (pH 7.4) for 30 min at 4 °C (61Badet-Denisot M.-A. Badet B. Arch. Biochem. Biophys. 1992; 292: 475-478Crossref PubMed Scopus (20) Google Scholar). Formation of N-carbethoxyhistidine residues was followed by the characteristic increase in absorbance at 240 nm (62Lundblad R.L. Noyes C.M. Chemical Reagents for Protein Modification. 1. CRC Press, Inc., Boca Raton, FL1988: 105-126Google Scholar). The modified protein was dialyzed extensively to remove excess DEPC, and its ability to aggregate at pH 7.4 and 6.6 with and without Cu2+, Fe3+, and Zn2+ was tested as described above. Subsequently, reversal of the histidine modification was achieved by incubating the modified protein with 0.1 mhydroxylamine hydrochloride in 25 mm phosphate buffer (pH 7.4) for 30 min at 4 °C. The restored peptide was dialyzed extensively to remove excess hydroxylamine hydrochloride, and its ability to aggregate at pH 7.4 and 6.6 with and without Cu2+, Fe3+ and Zn2+ was retested. Stock Aβ1–40 or Aβ1–42 (1 mg/ml) was diluted to a final concentration of 200 ng in 1 ml (44 nm) of buffer containing 150 mm NaCl, 20 mm Tris (pH 7.4 or 6.6), 0.1 μm BSA and CuCl2 (0, 0.1, 0.5, 1 or 5 μm), and the samples were mixed and then incubated (30 min, 37 °C). The reaction mixtures were then centrifuged at 12,000 × g for 10 min in a fixed angle rotor centrifuge, and the supernatant was carefully removed leaving a pellet of aggregated Aβ on the side of the tube. Sample buffer (30 μl; containing 4% SDS, 5% β-mercaptoethanol) was added to the tubes which were vigorously mixed, then heated to 95 °C for 5 min, and spun briefly. The SDS-extracted samples and a standard containing 50 ng of Aβ in sample buffer were loaded and analyzed by polyacrylamide gel electrophoresis (Tricine gels, 10–20%; Novex, San Diego, CA), transferred to polyvinylidene difluoride membranes (Bio-Rad), fixed, blocked, and then probed with the anti-Aβ monoclonal antibody 6E10 (Senetek, Maryland Heights, MI) overnight at 4 °C. The blot was then incubated with anti-mouse horseradish peroxidase conjugate (Pierce) for 2 h at 22 °C and incubated (5 min) with Supersignal Ultra (Pierce) according to the manufacturer's instructions. The chemiluminescent signal was captured for 10 min at maximum sensitivity using the Fluoro-S Image Analysis System (Bio-Rad), and the electronic images were analyzed using Multi-Analyst Software (Bio-Rad). This chemiluminescent image analysis system is linear over 2 orders of magnitude and has comparable sensitivity to film. Aβ1–40 or Aβ1–42 (~1 mg/ml) stock solutions were diluted to 20 nm in buffer containing 150 mm NaCl, 20 mm Tris (pH 7.4 or 6.6), 0.1 μm BSA and CuCl2 (0, 0.1, 0.2, 0.3, 0.5, 1, or 2 μm) added, and the samples were incubated (15 min, 37 °C). The reaction mixtures (200 μl) were then placed into the 96-well Easy-Titer ELIFA system (Pierce) and filtered through a 0.22-μm cellulose acetate filter (MSI, Westboro, MA). Aggregated particles were fixed to the membrane (0.1% glutaraldehyde, 15 min), washed thoroughly with Tris-buffered saline, and then probed with the anti-Aβ monoclonal antibody 6E10 (Senetek, Maryland Heights, MI) overnight at 4 °C. Blots were then processed as described above. To determine the effect of mild acidity on the behavior of Aβ in the presence of different metals, Aβ1–40 was incubated with different bioessential metal ions at pH 6.6, 6.8, and 7.4 at total metal ion concentrations observed in serum (Fig.1, A and B). Peptide aggregation was measured by sedimentation (Fig. 1 A) and turbidometry (Fig. 1 B), which generally gave confirmatory results. Incubation of Aβ in the absence of metal ions induced no detectable aggregation over the pH range tested. Only incubation with Zn2+ or Cu2+ induced >30% aggregation under these conditions (Fig. 1 A). As the [H+] was increased, all other metal ions induced an observable increase in sedimented Aβ (Fig. 1 A), but Cu2+ induced the most striking increase in Aβ aggregation as measured by both sedimentation and turbidometry. Fe3+induced a marked increase in turbidity (Fig. 1 B), but this aggregate was not as readily sedimented as the Cu2+- or Zn2+-induced Aβ aggregates (Fig. 1 A), probably due to decreased density of the assembly. As expected, Zn2+induced ~50% of the soluble peptide to sediment over the pH range tested, but increasing the [H+] caused a decrease in Zn2+-induced turbidity (Fig. 1 B) which may be due to an alteration in the size or light scattering properties of the Zn2+-induced aggregates. Incubation of the mixtures for 16 h did not induce any appreciable change in the turbidometry readings compared with the original readings (data not shown), suggesting that the aggregation reactions had reached equilibrium within 30 min. The effects of higher metal ion concentrations were also compared at equimolar (30 μm) concentrations (Fig. 1 C). Under these conditions, as the [H+] increased, Ni2+ induced Aβ aggregation (~85%) which was comparable to the effect of incubation with the same concentration of Cu2+. Co2+ induced a comparable level of Aβ aggregation to Zn2+ (~70%) and, like Zn2+, Co2+-induced aggregation was independent of [H+]. At 30 μm, Fe3+, Al3+, and Pb2+ were observed to induce partial (~30%) Aβ aggregation at pH 6.6 but no significant aggregation at pH 7.4. To quantify the binding affinity of Cu2+ for Aβ, spectral analysis was performed. The half-maximal binding of Cu2+for Aβ1–40 and Aβ1–42 based upon shift in absorbance was estimated as 4.0 and 0.3 μm, respectively (Fig. 2, A and B). The stoichiometry of Cu2+ binding to Aβ1–40in the Cu2+-induced Aβ aggregate was 3.4 and 3.0 at pH 7.0 and 6.6, respectively. The stoichiometry of Cu2+binding to Aβ1–40 required for precipitation is in agreement with that required for the saturation of the spectral shift (Fig. 2 A). Cu2+ supplied as a Cu2+-(glycine)2 complex did not alter the amount of Aβ aggregation or binding stoichiometry compared with that induced by non-complexed Cu2+ in the same buffer (data not shown). Next, w